MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
$60,441
Unit: Dollar
Positive Cash Flow Breakdown
    • Convertible notes payable
    • Accounts payable
    • Loan payable
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Loan from related parties
    • Due from subsidiaries
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-552,041
-808,904
-453,016
-487,589
Amortization
5,244
13,035
6,517
6,518
Prepaid expenses
-4,500
14,700
-10,650
1,930
Accounts payable
137,039
383,215
85,602
238,798
Net cash used in operating activities
-414,258
-397,954
-371,547
-240,343
Api acquisition
-58,600
-
-
-
Capital stock
-
-
-
-148
Net cash used in investing activities
-58,600
-
-
-
Additional paid in capital
-59,327
-
143,400
59,852
Loan payable
-
-
-
90,000
Capital stock
239
-
466
-
Convertible notes payable
365,395
-
-40,342
-100,464
Due from subsidiaries
-100,757
-
-
-
Loan from related parties
-129,756
-
68,492
119,816
Loan payable
116,285
-
90,000
-
Net cash provided by financing activities
533,299
329,104
453,480
169,352
Net cash increase (decrease) for period
60,441
-68,850
81,933
-70,991
Cash at beginning of period
23,145
91,995
81,053
-
Cash at end of period
83,586
23,145
91,995
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Convertible notes payable$365,395 (463.71%↑ Y/Y)something is missing$341,220 Loan payable$116,285 (29.21%↑ Y/Y)Capital stock$239 (261.49%↑ Y/Y)Net cash provided byfinancing activities$533,299 (214.91%↑ Y/Y)Canceled cashflow$289,840 Net cash increase(decrease) for period$60,441 (185.14%↑ Y/Y)Canceled cashflow$472,858 Loan from relatedparties-$129,756 (-208.30%↓ Y/Y)Due fromsubsidiaries-$100,757 Additional paid in capital-$59,327 (-199.12%↓ Y/Y)Accounts payable$137,039 (-42.61%↓ Y/Y)Amortization$5,244 (-19.55%↓ Y/Y)Net cash used inoperating activities-$414,258 (-72.36%↓ Y/Y)Net cash used ininvesting activities-$58,600 Canceled cashflow$142,283 Net loss-$552,041 (-13.22%↓ Y/Y)Api acquisition-$58,600 Prepaid expenses-$4,500 (-333.16%↓ Y/Y)

AVAI BIO, INC. (AVAI)

AVAI BIO, INC. (AVAI)